Group A streptococcus vaccine may be ready for phase I clinical trials in late 1989.
D000818:Animals; D000942:Antigens, Bacterial; D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins / Q000276:immunology; D001428:Bacterial Vaccines; D002352:Carrier Proteins; D006801:Humans; D051379:Mice; D012213:Rheumatic Fever / Q000453:epidemiology; D013290:Streptococcal Infections / Q000517:prevention & control*; D013297:Streptococcus pyogenes; D014612:Vaccines; D014614:Vaccines, Synthetic
D000942:Antigens, Bacterial; D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D002352:Carrier Proteins; D014612:Vaccines; D014614:Vaccines, Synthetic; C014689:streptococcal M protein